Updates are available Correction dated 2024-06-17
Click to view Correction: https://doi.org/10.1038/s41573-024-00993-6
-
Authors
Brennan, Richard J. https://orcid.org/0000-0002-0449-2730
Jenkinson, Stephen
Brown, Andrew https://orcid.org/0000-0002-5616-3664
Delaunois, Annie https://orcid.org/0000-0001-6345-7989
Dumotier, Bérengère https://orcid.org/0000-0002-3360-1510
Pannirselvam, Malar
Rao, Mohan
Ribeiro, Lyn Rosenbrier
Schmidt, Friedemann https://orcid.org/0000-0003-0265-0974
Sibony, Alicia
Timsit, Yoav
Sales, Vicencia Toledo
Armstrong, Duncan
Lagrutta, Armando https://orcid.org/0000-0002-0136-6210
Mittlestadt, Scott W.
Naven, Russell
Peri, Ravikumar
Roberts, Sonia
Vergis, James M. https://orcid.org/0009-0000-1362-2368
Valentin, Jean-Pierre https://orcid.org/0000-0002-3599-9155
- License Information
-
More Information
Article History
Accepted: 5 April 2024
First Online: 21 May 2024
Change Date: 17 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41573-024-00993-6
Competing interests
: A.B., A.D., B.D., M.P., M.R., L.R.R., F.S., A.S., Y.T., V.T.S., A.L., S.W.M., R.N., R.P., S.R. and J.-P.V. are employees of pharmaceutical companies. R.J.B. is a Director/Trustee and Scientific Advisory Board member of Lhasa Ltd., which manages the Effiris consortium. S.J. is an employee of a CRO providing screening services to pharmaceutical companies. D.A., R.J.B., S.J., A.B., A.D., M.P., M.R., L.R.R., F.S., A.S., Y.T., V.T.S., A.L., S.W.M., R.N., R.P., S.R. and J.-P.V. hold shares, share rights and/or stock options in pharmaceutical companies. J.M.V. declares no competing interests.
